Large-cap Health Care company Novo Nordisk A/S has logged a -1.4% change today on a trading volume of 4,562,466. The average volume for the stock is 4,821,804.
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. Based in Bagsvaerd, Denmark the company has 61,412 full time employees and a market cap of $456,534,884,352. Novo Nordisk A/S currently offers its equity investors a dividend that yields 6.9% per year.
The company is now trading -2.32% away from its average analyst target price of $102.78 per share. The 3 analysts following the stock have set target prices ranging from $79.83 to $124.29, and on average give Novo Nordisk A/S a rating of buy.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2020 | 126,946,000 | 42,138,000 | 33 | 0.0 |
| 2019 | 122,021,000 | 40,116,000 | 33 | -8.33 |
| 2018 | 111,831,000 | 39,925,000 | 36 | 0.0 |
| 2017 | 111,780,000 | 39,925,000 | 36 | 5.88 |
| 2016 | 111,780,000 | 37,925,000 | 34 | 3.03 |
| 2015 | 107,927,000 | 35,968,000 | 33 |
